Can micronized purified Flavonoid Fraction * (MPFF) improve outcomes of lower extremity varicose veinendovenous treatment? First results from the decision study

Phlebolymphology

Volumn 20, Issue 4, 2013, Pages 181-187

  Bogachev, Vadim Yu ^a   Golovanova, Olga V ^a   Kuznetsov, Alexey N ^a   Sheokyan, Anna O ^a  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Chronic venous disease; CIVIQ; Endovenous treatment; Micronized purified Flavonoid fraction (MPFF); Quality of life; Varicose disease; Venous scores

Indexed keywords

ALVENOR; ARDIUM; ARVENUM 500; CAPIVEN; DAFLON 500 MG; DETRALEX; ELATEC; FLAVONOID; FLEBOTROPIN; MICRONIZED PURIFIED FLAVONOID FRACTION; UNCLASSIFIED DRUG; VARITON; VENITOL;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPRESSION THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOVENOUS TREATMENT; EXPECTATION; FEMALE; FOLLOW UP; HUMAN; LEG VARICOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PATIENT SATISFACTION; POSTOPERATIVE CARE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VENOUS CLINICAL SEVERITY SCORING;

EID: 84890363236     PISSN: 12860107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Davies AH. Fast Facts: Vascular and Endovascular Surgery Highlights 2010-2011. Abingdon, UK: Health Press Limited;2011:88.
2. Gloviczki P. Handbook of Venous Disorders. Guidelines of the American Venous Forum. 3rd ed. London, UK: Hodder Arnold;2009:744.
3. Alam M, Nguyen TH. Treatment of Leg Veins. Philadelphia, USA: Elsevier Inc.;2006:195.
4. Goldman MP, Guex J-J, Weiss RA. Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. 5th ed. Philadelphia, USA: Elsevier Inc.;2011;401.
5. Cronenwett JL, Johnston KW. Rutherford's Vascular Surgery. 7th ed. Philadelphia, USA: Elsevier Inc.;2010:2448.
6. Pokrovsky AV, Saveljev VS, Kirienko AI, et al. Surgical correction of varicose vein disease under micronized diosmin protection (results of the Russian multicenter controlled trial DEFANS). Angiol Sosud Khir. 2007;13:47-55.
7. Veverkova L, Kalac J, Jedlicka V, Wechsler J. Analysis of surgical procedures on the vena saphena magna in the Czech Republic and an effect of Daflon 500 mg during its stripping. Rozhl Chir. 2005;84:410-412,414-416.
8. Veverkova L, Jedika V, Wechsler J, et al. Analysis of the various procedures used in great saphenous vein surgery in the Czech Republic and benefit of Daflon 500 mg on postoperative symptoms. Phlebolymphology. 2006;13:195-201.
9. Saveljev V, Pokrovsky A, Kirienko A, et al. Striping of the great saphenous vein under micronized purified flavonoid fraction (MPFF) protection (results of the Russian multicenter controlled trial DEFANCE). Phlebolymphology. 2008;15:43-51.
10. Bergan JJ, Pascarella L, Schmid-Schönbein G. Pathogenesis of primary chronic venous disease: insights from animal models of venous hypertension. J Vasc Surg. 2008;47:183-192.
11. Pascarella L, Lulic D, Penn AH, et al. Mechanisms in experimental venous valve failure and their modification by MPFF. Eur J Vasc Endovasc Surg. 2008;35:102-110.
12. Lyseng-Williamson A, Perry CM. Micronised purified flavonoid fraction. A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs. 2003;63:71-100.
13. Vasquez MA, Munschauer CE. Revised venous clinical severity score: a facile measurement of outcomes in venous disease. Phlebology. 2012;27(Suppl.1):119-129.
14. Vasquez MA. The importance of uniform venous terminology in reports on varicose veins. Phlebolymphology. 2011;18:130-139.
15. Vasquez MA, Rabe E, McLafferty RB, et al; American Venous Forum Ad Hoc Outcomes Working Group. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg. 2010;52:1387-1396.
16. Launois R, Lemoine JG, Lozano FS, Mansilha A. Construction and international validation of CIVIQ-14 (a short form of CIVIQ-20), a new questionnaire with a stable factorial structure. Quality of Life Research. 2012;21:1051-1058.
17. Alegre, P, Puskas, A, Giurcaneanu, C, Andercou, A, Jantet G. Absenteeism and impaired quality of life in chronic venous disease in patients in Romania. ISPOR 13th Annual European congress research abstracts. Value in Health. 2010;13:A239-A250.
18. Darvall KA, Bate GR, Sam RC, Adam DJ, Silverman SH, Bradbury AW. Patients' expectations before and satisfaction after ultrasound guided foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg. 2009;38:642-647.